Frontlight ResearchEarly access
Pompe disease trials in Russia
1 of 1 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseCompletedPompe Disease Registry Protocol
- Where
- Moscow
- People
- 2,000 worldwide
- Run by
- Genzyme, a Sanofi Company
See details and how to joinNCT00231400